Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Gains from Investment Securities (2024 - 2025)

Connect Biopharma Holdings' Gains from Investment Securities history spans 2 years, with the latest figure at -$41000.0 for Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 136.94% year-over-year to -$41000.0; the TTM value through Sep 2025 reached -$145000.0, changed N/A, while the annual FY2023 figure was -$238000.0, N/A changed from the prior year.
  • Gains from Investment Securities for Q3 2025 was -$41000.0 at Connect Biopharma Holdings, down from $41000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $111000.0 in Q3 2024 and bottomed at -$111000.0 in Q4 2024.